Lower Limb Spasticity

2

Review clinical trials related to Lower Limb Spasticity. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity

The goal of this clinical trial is to find out if Vibrotactile Stimulation (VTS) can help improve mobility and reduce spasticity (muscle stiffness) in people with lower limb spasticity. The study will also look at how VTS affects walking speed. The main questions it aims to answer are: * Which areas of the body are the best for applying VTS? * Does VTS help improve walking speed in people with lower limb spasticity? Participants will: * Receive 15 minutes of VTS treatment on different parts of the body * Use the VTS device for 60 minutes during supervised lab sessions and at home (at rest and while walking) * Complete a daily log of how much time the device was used for and note any issues or difficulties the participant experience * Complete assessments after the treatment to measure change in mobility * Complete surveys about how comfortable the device is to use

Participants needed: 25
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: Weill Medical College of Cornell UniversityUpdated: Jun 17, 2026Locations: 1
Eligibility criteria

≥6 months following neurologic diagnosis leading to spasticity [+3]

Uncontrolled systemic illness or serious medical conditions that could interfere... [+4]

Status: Not yet recruiting

Effect of Extracorporeal Shock Wave Therapy on Spasticity and Mobility in Stroke Patients

This study aims to evaluate the effectiveness of extracorporeal shock wave therapy (ESWT) in individuals with lower limb spasticity following stroke. Spasticity is a common complication after stroke and can negatively affect walking ability, mobility, and quality of life. Participants will be randomly assigned to one of two groups. Both groups will receive a standard physiotherapy and rehabilitation program. In addition, the intervention group will receive ESWT applied to the lower limb muscles, while the control group will receive a sham (placebo) ESWT application. The treatment program will be conducted three times per week for four weeks. Clinical assessments will be performed at baseline, after treatment, and during follow-up. The main outcomes of the study include muscle tone (spasticity), walking performance, motor function, and quality of life. The results of this study may help improve rehabilitation strategies and provide evidence for the use of ESWT in stroke patients.

Participants needed: 85
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Istanbul Medipol University HospitalUpdated: Apr 14, 2026
Eligibility criteria

Adults aged 18-65 years [+4]

Receipt of botulinum toxin injection in the affected lower limb within the last... [+6]